Skip to main content
. Author manuscript; available in PMC: 2019 Sep 24.
Published in final edited form as: Vaccine. 2016 Apr 19;34(26):2939–2947. doi: 10.1016/j.vaccine.2016.03.111

Fig. 2.

Fig. 2.

Global and regional estimates of the number of prevalent cases of HSV-2 infection among 15–49 year-olds in 2012. Global total = 417 million prevalent infections [2].